| - GRCh37:
- Chr3:150659446
- GRCh38:
- Chr3:150941659
| CLRN1 | F119S, F43S | Usher syndrome type 3A | Uncertain significance (Nov 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690347-150690348
- GRCh38:
- Chr3:150972560-150972561
| CLRN1 | S50fs | Retinitis pigmentosa, Usher syndrome type 3A, Retinitis pigmentosa 61, not provided | Pathogenic (May 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645725
- GRCh38:
- Chr3:150927938
| CLRN1 | | Usher syndrome type 3A | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:150690308
- GRCh38:
- Chr3:150972521
| CLRN1 | Y63S | Usher syndrome type 3A, Usher syndrome | Pathogenic/Likely pathogenic (Feb 12, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr3:150690288
- GRCh38:
- Chr3:150972501
| CLRN1 | G70C | not provided | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150659534
- GRCh38:
- Chr3:150941747
| CLRN1 | A147G, L14V, L90V | Usher syndrome type 3A | Uncertain significance (Aug 14, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr3:150659480
- GRCh38:
- Chr3:150941693
| CLRN1 | L108F, L32F, P165L | Retinitis pigmentosa, Usher syndrome type 3A, Retinitis pigmentosa 61, not provided | Uncertain significance (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150659396
- GRCh38:
- Chr3:150941609
| CLRN1 | G136R, G60R | Retinitis pigmentosa, Usher syndrome type 3A, Retinitis pigmentosa 61, not provided | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150659359
- GRCh38:
- Chr3:150941572
| CLRN1 | | not provided | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690404
- GRCh38:
- Chr3:150972617
| CLRN1 | P31R | not provided | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150645893
- GRCh38:
- Chr3:150928106
| CLRN1 | V101I, V177I, V190I | not provided | Uncertain significance (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150659532
- GRCh38:
- Chr3:150941745
| CLRN1 | Q148E | not provided | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690476
- GRCh38:
- Chr3:150972689
| CLRN1, CLRN1-AS1 | K7I | not provided, Usher syndrome type 3 | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150661472
- GRCh38:
- Chr3:150943685
| CLRN1 | | not provided, Usher syndrome type 3A | Benign (Jun 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150661495
- GRCh38:
- Chr3:150943708
| CLRN1 | | not provided, Usher syndrome type 3A | Benign (Jun 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150661842
- GRCh38:
- Chr3:150944055
| CLRN1 | | not provided, Usher syndrome type 3A | Benign (Jun 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150659395
- GRCh38:
- Chr3:150941608
| CLRN1 | G136E, G60E | Usher syndrome type 3A, not provided | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690278
- GRCh38:
- Chr3:150972491
| CLRN1 | Q73R | Usher syndrome type 3, not specified, not provided, Retinitis pigmentosa, Retinitis pigmentosa 61, Usher syndrome type 3A
| Uncertain significance (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690313
- GRCh38:
- Chr3:150972526
| CLRN1 | M61I | Usher syndrome type 3A, Inborn genetic diseases, not provided, Usher syndrome type 3 | Uncertain significance (Feb 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645803
- GRCh38:
- Chr3:150928016
| CLRN1 | R207*, R220* | not provided, Usher syndrome type 3A, Retinitis pigmentosa 61, Retinitis pigmentosa, Usher syndrome type 3 | Pathogenic (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150644685
- GRCh38:
- Chr3:150926898
| CLRN1 | | not provided, Usher syndrome type 3A, Usher syndrome type 3
| Conflicting interpretations of pathogenicity (Jan 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150658264
- GRCh38:
- Chr3:150940477
| CLRN1 | | Usher syndrome type 3A, not specified, not provided
| Benign (Jun 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645919-150645920
- GRCh38:
- Chr3:150928132-150928133
| CLRN1 | I92fs, I168fs, I181fs | Usher syndrome, Retinal dystrophy, not provided, Retinitis pigmentosa 61, Usher syndrome type 3, Retinitis pigmentosa 61, Usher syndrome type 3A, Retinitis pigmentosa | Pathogenic/Likely pathogenic (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690344-150690347
- GRCh38:
- Chr3:150972557-150972560
| CLRN1 | S50fs | not provided, Rare genetic deafness, Retinal dystrophy, Usher syndrome type 3, Retinitis pigmentosa, Retinitis pigmentosa 61, Usher syndrome type 3A | Pathogenic/Likely pathogenic (May 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645762
- GRCh38:
- Chr3:150927975
| CLRN1 | | not specified, not provided, Usher syndrome type 3
| Conflicting interpretations of pathogenicity (Oct 30, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150690487
- GRCh38:
- Chr3:150972700
| CLRN1, CLRN1-AS1 | S3R | not specified, not provided | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150690490
- GRCh38:
- Chr3:150972703
| CLRN1, CLRN1-AS1 | | not provided, Usher syndrome type 3, not specified
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690439
- GRCh38:
- Chr3:150972652
| CLRN1 | | Usher syndrome type 3, Usher syndrome type 3A, not provided, not specified | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150659434
- GRCh38:
- Chr3:150941647
| CLRN1 | A123D, A47D, C180* | Usher syndrome type 3A, Rare genetic deafness, Usher syndrome, not provided, Usher syndrome type 3 | Pathogenic/Likely pathogenic (Sep 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645961
- GRCh38:
- Chr3:150928174
| CLRN1, CLRN1-AS1 | L154W, L167W, L78W | Usher syndrome type 3A | Likely pathogenic (Jan 30, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690378
- GRCh38:
- Chr3:150972591
| CLRN1 | C40G | Usher syndrome, Retinal dystrophy, not provided, Usher syndrome type 3 | Conflicting interpretations of pathogenicity (Dec 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:150690307
- GRCh38:
- Chr3:150972520
| CLRN1 | Y63* | Usher syndrome type 3A, Rare genetic deafness, not provided, Usher syndrome type 3 | Pathogenic (Sep 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690352
- GRCh38:
- Chr3:150972565
| CLRN1, CLRN1-AS1 | N48K | Usher syndrome type 3A, Rare genetic deafness, Retinal dystrophy, not specified, not provided, Retinitis pigmentosa, Usher syndrome type 3, Usher syndrome type 3A, Retinitis pigmentosa 61, Retinitis pigmentosa | Pathogenic/Likely pathogenic (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150645894
- GRCh38:
- Chr3:150928107
| CLRN1 | Y176*, Y100*, Y189* | Rare genetic deafness, not provided, Retinitis pigmentosa, Usher syndrome type 3, Hearing impairment, Retinitis pigmentosa, Usher syndrome type 3A, Retinitis pigmentosa 61 | Pathogenic/Likely pathogenic (Oct 29, 2022) | criteria provided, multiple submitters, no conflicts |